| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/08/1995 | EP0637337A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine |
| 02/08/1995 | EP0637336A1 Mn gene and protein |
| 02/08/1995 | EP0637335A1 Recombinant mutants for inducing specific immune responses |
| 02/08/1995 | EP0637334A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637319A1 A novel anti-neoplastic cytokine |
| 02/08/1995 | EP0637318A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 02/08/1995 | EP0637317A1 Method for purifying an aqueous solution of raw albumin |
| 02/08/1995 | EP0637316A1 Antisense oligonucleotide inhibition of papillomavirus |
| 02/08/1995 | EP0637296A1 Non-steroid progesterone receptor agonist and antagonist compounds and methods |
| 02/08/1995 | EP0637250A1 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 02/08/1995 | EP0637249A1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides |
| 02/08/1995 | EP0637246A1 Methods of treating cancer using modified c-reactive protein |
| 02/08/1995 | EP0637237A1 Calcium receptor-active molecules |
| 02/08/1995 | EP0637201A1 Method for inducing tumor immunity |
| 02/08/1995 | EP0536203B1 COMBINED TREATMENT WITH GnRH ANTAGONIST AND GnRH TO CONTROL GONADOTROPIN LEVELS IN MAMMALS |
| 02/08/1995 | EP0386222B1 Process for preparing human serum albumine by fermenting a genetically engineered microorganism in the presence of a polyalkylene compound |
| 02/08/1995 | CN1098416A Process for producing hydrophobic polypeptides, proteins or peptides |
| 02/07/1995 | US5387746 Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereof |
| 02/07/1995 | US5387744 Avirulent microbes and uses therefor: Salmonella typhi |
| 02/07/1995 | US5387742 Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease |
| 02/07/1995 | US5387676 MN gene and protein |
| 02/07/1995 | US5387673 Active fragments of fibroblast growth factor |
| 02/07/1995 | US5387672 Hemoglobin intramolecularly cross-linked withlong chain divalent reagents |
| 02/07/1995 | US5387671 Antiinflammatory agents |
| 02/07/1995 | US5387583 Compositions containing corticosteroids or analogues thereof and corticosteroid buffering effective amounts of 5-androstene 3B, 17B or 5-androstene 3B, 7B, 17B triol or analogues thereof |
| 02/07/1995 | US5387576 Treatment of hyperproliferative epidermal conditions with activin A |
| 02/07/1995 | US5387520 Treatment of tumor cells in vitro with neurotrophic factors and cell proliferation inhibitors |
| 02/07/1995 | US5387511 Extraction procedure for Chlamydia and Neisseria antigens |
| 02/07/1995 | US5387505 Preparation and isolation of single-stranded biotinylated nucleic acids by heat avidin-biotin cleavage |
| 02/07/1995 | US5387504 Monospecific antibodies and assay system for detecting stromelysin cleavage products |
| 02/07/1995 | US5387414 Comprising peptide immunogen with novel epitopes |
| 02/07/1995 | CA1334287C Biologically active peptides tan-866 |
| 02/04/1995 | CA2104237A1 Agents for diagnosis, treatment and cure of amyotrophic lateral sclerosis in humans |
| 02/02/1995 | WO1995003547A1 Methods for determining the invasiveness of a bladder tumor |
| 02/02/1995 | WO1995003422A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 02/02/1995 | WO1995003418A2 Recombinant bcg vaccines |
| 02/02/1995 | WO1995003417A2 Homologously recombinant slow growing mycobacteria and uses therefor |
| 02/02/1995 | WO1995003415A2 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 02/02/1995 | WO1995003413A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
| 02/02/1995 | WO1995003412A2 Nucleotide fragment of mycobacterial ribosomal rna 23s, probes and primers derived therefrom, reagent and method for detecting said fragment |
| 02/02/1995 | WO1995003411A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | WO1995003410A2 Guanylatcyclase activating peptide i (gcap-i) coding gene |
| 02/02/1995 | WO1995003409A1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003405A2 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | WO1995003403A1 Methods and compositions incorporating ip-10 |
| 02/02/1995 | WO1995003402A1 EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL |
| 02/02/1995 | WO1995003399A2 Production method for preparation of disabled viruses |
| 02/02/1995 | WO1995003397A1 Transgenic animal model for cognitive disorders |
| 02/02/1995 | WO1995003335A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | WO1995003334A1 Antibodies specific for human prostate glandular kallikrein |
| 02/02/1995 | WO1995003333A2 Tryptase inhibitor |
| 02/02/1995 | WO1995003332A1 Activated human factor viii and method of preparation |
| 02/02/1995 | WO1995003331A1 Human mhc class ii double transgene and uses |
| 02/02/1995 | WO1995003330A1 Somatostatin derivatives and their radiolabelled products |
| 02/02/1995 | WO1995003329A2 Selective amylin antagonist peptides and uses therefor |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003322A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | WO1995003070A1 Recombinant swinepox virus |
| 02/02/1995 | WO1995003069A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | WO1995003065A1 Scorpion peptide with immunosuppressant activity |
| 02/02/1995 | WO1995003064A1 Polymeric carriers for non-covalent drug conjugation |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | WO1995003034A1 Stabilization of aerosolized proteins |
| 02/02/1995 | WO1994029447A3 Dna coding for the human thyrotropin-releasing hormone receptor |
| 02/02/1995 | WO1994029442A3 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 02/02/1995 | WO1994029350A3 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/02/1995 | WO1994028136A3 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes |
| 02/02/1995 | WO1994028129A3 Tumour metastasis gene |
| 02/02/1995 | WO1994026925A3 Processes for producing an enzyme |
| 02/02/1995 | WO1994018329A3 Serine protease variants having peptide ligase activity |
| 02/02/1995 | DE4325699A1 Recombinant DNA construct |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/02/1995 | CA2168232A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | CA2168110A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | CA2168096A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | CA2167808A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | CA2167677A1 Method for the high level expression, purification and refolding of the outer membrane group b porin proteins from neisseria meningitidis |
| 02/02/1995 | CA2167581A1 Transgenic animal model for cognitive disorders |
| 02/02/1995 | CA2167580A1 Expression of human interleukin-1.beta. in a transgenic animal |
| 02/02/1995 | CA2167574A1 Polymeric carriers for non-covalent drug conjugation |
| 02/02/1995 | CA2167538A1 Stabilization of aerosolized proteins |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167301A1 Selective amylin antagonist peptides and uses therefor |
| 02/02/1995 | CA2167267A1 Methods for determining the invasiveness of a bladder tumor |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166870A1 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | CA2166616A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | CA2164221A1 Tryptase inhibitor |
| 02/02/1995 | CA2145172A1 Nucleotide fragment of mycobacterial ribosomal rna 23s, probes and primers derived therefrom, reagent and method for detecting said fragment |
| 02/01/1995 | EP0636696A1 Process for producing major histocompatibility antigen class ii protein and material having the same immobilized thereon |
| 02/01/1995 | EP0636694A2 Human and human-like thymopoietin, method for its production and recombinant DNA sequences encoding it |